Results 11 to 20 of about 6,936,275 (302)

MHC II–EGFP Knock‐in Mouse Model [PDF]

open access: yesCurrent Protocols, 2023
AbstractThe MHC II–EGFP knock‐in mouse model enables us to visualize and track MHC‐II‐expressing cells in vivo by expressing enhanced green fluorescent protein (EGFP) fused to the MHC class II molecule under the MHC II beta chain promoter. Using this model, we can easily identify MHC‐II‐expressing cells, including dendritic cells, B cells, macrophages,
Jan Pačes   +7 more
openaire   +4 more sources

Conditional Ablation of MHC-II Suggests an Indirect Role for MHC-II in Regulatory CD4 T Cell Maintenance [PDF]

open access: yesThe Journal of Immunology, 2006
Abstract Although the importance of MHC class II (MHC-II) in acute homeostatic proliferation of regulatory T (Treg) cells has been established, we considered here the maintenance and state of Treg cells in mice that are almost completely devoid of MHC-II in their periphery but still make their own CD4 T cells and Treg cells.
Michiko, Shimoda   +7 more
openaire   +3 more sources

Regulation of MHC Class II-Peptide Complex Expression by Ubiquitination

open access: yesFrontiers in Immunology, 2013
MHC class II (MHC-II) molecules are present on antigen presenting cells (APCs) and these molecules function by binding antigenic peptides and presenting these peptides to antigen-specific CD4+ T cells.
Kyung Jin eCho, Paul A. Roche
doaj   +2 more sources

Human Intestinal Enteroids Model MHC-II in the Gut Epithelium [PDF]

open access: yesFrontiers in Immunology, 2019
The role of intestinal epithelial cells (IECs) in mucosal tolerance and immunity remains poorly understood. We present a method for inducing MHC class II (MHC-II) in human enteroids, “mini-guts” derived from small intestinal crypt stem cells, and show ...
Jonathan E. Wosen   +9 more
doaj   +3 more sources

Essential role of MHC II in the antitubercular efficacy of pyrazinamide. [PDF]

open access: yesAntimicrob Agents Chemother
Abstract Antibacterial drug mechanisms have traditionally been examined through a drug-pathogen lens, often overlooking the host’s role in shaping drug activity. However, growing evidence suggests that the host environment is crucial for antibacterial efficacy.
Lamont EA   +7 more
europepmc   +4 more sources

The melting pot of the MHC II peptidome [PDF]

open access: yesCurrent Opinion in Immunology, 2016
Recent advances in mass spectrometry technology have facilitated detailed examination of MHC-II immunopeptidomes, for example the repertoires of peptides bound to MHC-II molecules expressed in antigen presenting cells. These studies have deepened our view of MHC-II presentation.
Lawrence J, Stern, Laura, Santambrogio
openaire   +2 more sources

TRIM22 negatively regulates MHC-II expression

open access: yesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2022
The development of cancer treatment has recently achieved a remarkable breakthrough, and checkpoint blockade immunotherapy has received much attention. To enhance the therapeutic efficacy of checkpoint blockade immunotherapy, recent studies have revealed the importance of activation of CD4+ T cells via an increase in major histocompatibility complex ...
Inoue, Ayano   +4 more
openaire   +3 more sources

MHC-II binding prediction results of VirB8 (IEDB).

open access: yes, 2023
MHC-II binding prediction results of VirB8 (IEDB).
Ce Niu (16814125)   +10 more
core   +1 more source

MHC-II Signature Correlates With Anti-Tumor Immunity and Predicts anti-PD-L1 Response of Bladder Cancer

open access: yesFrontiers in Cell and Developmental Biology, 2022
A large proportion of anti-tumor immunity research is focused on major histocompatibility complex class I (MHC-I) molecules and CD8+ T cells. Despite mounting evidence has shown that CD4+ T cells play a major role in anti-tumor immunity, the role of the ...
Ruibin Yi   +11 more
doaj   +1 more source

MHC-II binding prediction results of VirB10 (IEDB).

open access: yes, 2023
MHC-II binding prediction results of VirB10 (IEDB).
Ce Niu (16814125)   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy